Longeveron Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LGVN | BRTX | NCEL | AIM | CELU | BCDA | |
|---|---|---|---|---|---|---|
| Market cap | 5.67M | 2.09M | 14.79M | 6.42M | 26.25M | 13.82M |
| P/E (TTM) | — | — | 4.9 | — | — | — |
| Forward P/E | -1.2 | -0.1 | -4.3 | -0.4 | -1.4 | -1.6 |
| Price/book | 0.5 | 0.6 | 2.3 | 0.6 | -0.7 | 5.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −76.64% | −94.93% | −38.31% | −90.12% | −52.13% | −28.91% |
| Today | 0.00% | +2.03% | −3.03% | +0.19% | −1.02% | −0.92% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All LGVN news ›iPower Inc. Announces 1-for-12 Reverse Stock Split
Asia Broadband Board Approves Additional $18 Million for Stock Repurchases, Bringing Authorized Total Repurchases Up to $30 Million SOAR AI Releases Investor Presentation Outlining its Planned Path from the Initial $1.17 Billion of…
Longeveron’s stem cell data hint at calmer brains
What they report is encouraging, with plenty of fine print. Laromestrocel, the company’s cell therapy (also known as Lomecel-B), appeared to slow the progression of neuroinflammation. The strongest effects showed up in areas at the heart…
Longbridge Financial Names Larissa Morrell Vice President of Product Development
Longbridge Financial today announced the promotion of Larissa Morrell to vice president of product development as the company continues to develop and expand its home equity product portfolio. Larissa Morrell Named Vice President of…
Nextplat announces 1-for-10 reverse stock split to be effective prior to market open on April 13, 2026
NextPlat Corp: NextPlat announces 1-for-10 reverse stock split to be effective prior to market open on April 13, 2026 ... Nextplat announces 1-for-10 reverse stock split to be effective prior to market open on April 13, 2026 Published on…
Reviewing Marker Therapeutics (NASDAQ:MRKR) and Longeveron (NASDAQ:LGVN)
Posted by Sarita Garza on Oct 7th, 2026 Longeveron (NASDAQ:LGVN – Get Free Report) and Marker Therapeutics (NASDAQ:MRKR – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two…
Longxing Technology's Shareholder Plans To Unload Shares
TradingView Longxing Technology's Shareholder Plans To Unload Shares
Longeveron CEO Stephen H. Willard Discloses RSU Tax Withholding Share Disposal
OFS Capital Receives $52.28M from Sale of 56.62% Stake in SBIC I LP On October 5, 2026, a Form 4 filing revealed that Stephen H. Willard, CEO of Longeveron Inc. (NASDAQ:LGVN) LGVN (NASDAQ:LGVN) , disposed of 1,987 shares of Class A Common…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- biospace.com1
- housingwire.com1
- kalkinemedia.com1
- marketscreener.com1
- rutlandherald.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.